Marketing

About Marketing

This author has not yet filled in any details.
So far Marketing has created 93 blog entries.

District of Columbia Annual Healthcare Provider Disclosure Reports Due July 1st

District of Columbia Annual Healthcare Provider Disclosure Reports Due July 1st

Annual disclosures are required by pharmaceutical manufacturers and are due July 1st along with a $5,000 filing fee. Gift expenses, advertising expenses and employee cost are reportable. Reporting requirements depend on the type of activity being disclosed. Expenditures for consulting and honoraria fees, charitable grants, […]

Connecticut Annual Healthcare Provider Disclosure Reports Due July 1st

Connecticut Annual Healthcare Provider Disclosure Reports Due July 1st

By July 1st each year, pharmaceutical and medical device manufacturers that provide a payment or other transfer of value to an advanced practice registered nurse, who is not practicing in collaboration with a physician in the state, shall submit a disclosure report. The Department of Consumer […]

Massachusetts Annual Healthcare Provider Disclosure Reports Due July 1st

Massachusetts Annual Healthcare Provider Disclosure Reports Due July 1st

Annual disclosures are required by pharmaceutical and medical device manufacturers. Prior to submission, registration or annual renewal is required which includes a $2000 fee each year. Manufacturers are required to disclose certain transactions with anyone who prescribes, dispenses, or purchases prescription drugs or medical devices […]

Minnesota Pharmaceutical Manufacturer Disclosure Reports Due May 1st

Minnesota Pharmaceutical Manufacturer Disclosure Reports Due May 1st

All payments, honoraria, reimbursement, or other compensation paid to practitioners in Minnesota during the preceding calendar year are to be reported. The report must identify the nature and value of any payments totaling $100 or more to a particular practitioner during the year as well as the practitioners […]

Program Year 2017 Data Submission Reminder

Program Year 2017 Data Submission Reminder

Saturday, March 31, 2018 is the final day to submit and attest to data for the June  30, 2018 publication of Program Year 2017 data. Data must be submitted by 11:59 p.m. (ET) on March 31, 2017.

• Data submission and attestation activities can be completed by logging into the Open […]

Updated Vermont URL and Contact Information

In March, 2018:  The state of Vermont changed their URL.

The new link is: http://ago.vermont.gov/disclosures-manufacturers-prescription-drugs-biological-products-medical-devices/.

To ask questions and submit notices please use: ago.prescribedproducts@vermont.gov

To submit disclosures please use:  ago.vtpharma@vermont.gov

Maine Pharmacy Act – Prohibited Gifts to Practitioners

Title 32: PROFESSIONS AND OCCUPATIONS

Chapter 117: MAINE PHARMACY ACT

Subchapter 6: MANUFACTURERS AND WHOLESALERS 

  • 13759. Gifts to practitioners prohibited
  1. Prohibition. Except as provided in subsection 2, a manufacturer or wholesaler licensed under section 13758 or an agent of a manufacturer or wholesaler licensed under section 13758 may not offer or give the following to a practitioner:
  2. […]

Update: Nevada Transparency Law Reporting Requirements – Senate Bill 539

Update: Nevada Transparency Law Reporting Requirements – Senate Bill 539 (Scroll down to see impacted drugs)

The transparency law applies equally to all pharmaceutical representatives and not just those who are engaging in the sales and marketing of the diabetes-related treatments.

Pharmaceutical Representative List Submission

Section 4.6(1) of […]

New Jersey: Limitations on and Obligations Associated with Acceptance of Compensation…

Limitations on and Obligations Associated with Acceptance of Compensation from Pharmaceutical Manufacturers by Prescribers

N.J.A.C. 13:45J-1.1, 1A, 2, 3, 4, 5, 6, 7, 8
Effective: January 16, 2018

The provisions of this rule apply to contracts entered into on or after January 16, 2018.

Background: The new rules are designed to reduce incentives for treatment decisions to be influenced […]

MMIS President and CEO Michaeline Daboul to Speak at the 3rd Annual Global Compliance Congress for Life Sciences

Global Compliance Remains a Focus for Life Science Companies as Britain Negotiates Its Exit from the European Union

Portsmouth, NH, November 2, 2016– MMIS President and CEO Michaeline Daboul will be speaking at the CBI 3rd Annual Global Compliance Congress for Life Sciences, in London on November 16-17. “As Brexit continues, pharmaceutical and medical device […]